Retinopathy of prematurity (ROP) is one of the most common—and preventable—causes of childhood blindness worldwide. Among the 15 million babies born preterm (before 37 completed weeks of gestation) each year, approximately 15 to 20% are affected by ROP.

With early diagnosis, appropriate treatment, and preventive care, healthcare professionals can play a critical role in protecting the eyesight of vulnerable infants.

For detailed information on the risk factors, diagnosis, and treatment options for ROP, download our evidence-based factsheet, available in English and German.

All content on ROP was independently developed by EFCNI (now GFCNI) and reviewed by external experts for medical accuracy.

Novartis Pharma AG supported the topic of ROP but had no influence on its content or messaging.